However, due to sampling bias and tumor heterogeneity, both within and across patient-derived tumor tissue specimens, HER2 expression levels from a limited number of tissue biopsy cores cannot always be accurately characterized and require an invasive procedure that can significantly impair quality of life for these patients41. Here, ERBB2 is linked to neoplasm.